Virtual Reality (VR) is providing experiences to healthcare professionals and patients, while deepening learning and high-quality training for HCPs and an empathy treatment for patients.
VR, or 360-degree video, can help to address medicine adherence by telling the story of patient journeys through deep visualisations of their conditions, disease states or therapies. Using VR not only increases the efficiency of the predevelopment phases but also enables the scientists to visualise interactions and redesign and re-engineer molecules according to site specifications.
A virtual tech is a powerful tool for representing information, especially the more complex concepts and ideas, the likes you would encounter in medical science. We have already mentioned before how VR is used for visualising physiological processes, handling models of chemical compounds and molecules and so on. It has always been better to see such things once for yourself than trying to figure it all out by contemplating dozens of pages of written descriptions. It is no wonder that medical specialists are highly interested.
Modern VR also builds upon mechanism of action (MOA) animations, which are a mainstay in pharmaceutical marketing. While MOAs provide clear and concise information about drugs, most animations offer the patients or healthcare professionals the experience of being in the bloodstream or penetrating a cell wall to deliver healing medicine.
Pharmaceutical companies can also use VR technology to promote brand awareness. Consumers are far more likely to remember the extraordinary experience of VR than a PowerPoint presentation.
Pharmaceutical companies can use VR in medical conventions rather than hauling around heavy, expensive equipment. VR also helps convention attendees engagingly explore the mechanism of action.
VR and Augmented Reality (AR) could help to improve care and outcomes for patients and allow healthcare providers to communicate therapy options. Complex medical information can be broken down into visual concepts that can be downloaded through an app and viewed on a smartphone.
AR / VR and the combination of Artificial Intelligence (AI) can be a ground-breaking frontier for pharmaceutical research. An intelligently adapting AR / VR enabled research platform can have the ability to create bodies of knowledge that can be used to tackle major health concerns.
While large pharmaceutical companies have started adopting AR / VR and there have been many successful use cases, the easy availability of these technologies, smaller pharmaceutical companies can also start using them. Not only do these technologies have the ability to cut costs for various processes and improve outcomes but they can also give adopters a significant advantage in this increasingly competitive pharmaceutical landscape.
For more information, please fill out the enquiry form attached to this page.